[link removed]
FAIR
View article on FAIR's website ([link removed])
David Himmelstein on Medicare Dis-Advantage, Tauhid Chappell on Cannabis Equity CounterSpin ([link removed])
Subscribe: RSS ([link removed])
[link removed]
Common Dreams: A $600 Billion Swindle: Study Makes Case to 'Abolish' Medicare Advantage
Common Dreams (6/10/24 ([link removed]) )
This week on CounterSpin: Headlined “The Cash Monster Was Insatiable,” a 2022 New York Times piece ([link removed]) reported insurance companies gaming Medicare Advantage, presented as a "low-cost" alternative to traditional Medicare. One company pressed doctors to add additional illnesses to the records of patients they hadn’t seen for weeks: Dig up enough new diagnoses, and you could win a bottle of champagne. Some companies cherry-picked healthier seniors for enrollment with cynical tricks like locating their offices up flights of stairs.
Such maneuvers don’t lead to good health outcomes, but they serve the real goal: netting private insurers more money. There is now new research ([link removed]) on the problem, and the response. We hear from David Himmelstein, co-founder of Physicians for a National Health Program ([link removed]) and co-author of this new analysis of Medicare Advantage.
[link removed]
Recreational Plus Cannabis Dispensary, unlicensed weed store in New York's East Village
(CC photo: Jim Naureckas)
Also on the show: You may get the impression from media that marijuana is legal everywhere now, that it’s moved from blight to business, if you will. It’s not as simple as that, and many people harmed by decades of criminalization have yet to see any benefit from decriminalization. Tauhid Chappell has tracked the issue for years now; he teaches the country’s first graduate-level course on equity movements in the cannabis industry, at Thomas Jefferson University ([link removed]) . We’ll get an update from him.
[link removed]
Plus Janine Jackson takes a quick look at recent press coverage of Julian Assange ([link removed]) .
[link removed]
Read more ([link removed])
Share this post: <a rel="nofollow" target="_blank" href="[link removed]" title="Twitter"><img border="0" height="15" width="15" src="[link removed]" title="Twitter" alt="Twitter" class="mc-share"></a>
<a rel="nofollow" target="_blank" href="[link removed]" title="Facebook"><img border="0" height="15" width="15" src="[link removed]" title="Facebook" alt="Facebook" class="mc-share"></a>
<a rel="nofollow" target="_blank" href="[link removed]" title="Pinterest"><img border="0" height="15" width="15" src="[link removed]" title="Pinterest" alt="Pinterest" class="mc-share"></a>
<a rel="nofollow" target="_blank" href="[link removed]" title="LinkedIn"><img border="0" height="15" width="15" src="[link removed]" title="LinkedIn" alt="LinkedIn" class="mc-share"></a>
<a rel="nofollow" target="_blank" href="[link removed]" title="Google Plus"><img border="0" height="15" width="15" src="[link removed]" title="Google Plus" alt="Google Plus" class="mc-share"></a>
<a rel="nofollow" target="_blank" href="[link removed]" title="Instapaper"><img border="0" height="15" width="15" src="[link removed]" title="Instapaper" alt="Instapaper" class="mc-share"></a>
© 2021 Fairness & Accuracy in Reporting. All rights reserved.
You are receiving this email because you signed up for email alerts from
Fairness & Accuracy in Reporting
Our mailing address is:
FAIRNESS & ACCURACY IN REPORTING
124 W. 30th Street, Suite 201
New York, NY 10001
FAIR's Website ([link removed])
FAIR counts on your support to do this work — please donate today ([link removed]) .
Follow us on Twitter ([link removed]) | Friend us on Facebook ([link removed])
change your preferences ([link removed])
Email Marketing Powered by Mailchimp
[link removed]
unsubscribe ([link removed]) .
